Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
8.33
-0.19 (-2.23%)
Apr 24, 2025, 11:35 AM EDT - Market open
Aardvark Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$31.50
Upside
+278.15%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $21 | Buy | Reiterates | $21 | +152.10% | Apr 1, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $50 | Buy | Reiterates | $50 | +500.24% | Apr 1, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $22 → $26 | Strong Buy | Maintains | $22 → $26 | +212.12% | Mar 27, 2025 |
| RBC Capital | RBC Capital | Buy Initiates $21 | Buy | Initiates | $21 | +152.10% | Mar 10, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $50 | Buy | Initiates | $50 | +500.24% | Mar 10, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $29 | Buy | Initiates | $29 | +248.14% | Mar 10, 2025 |
| B of A Securities | B of A Securities | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +164.11% | Mar 10, 2025 |